ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MXCT MaxCyte Inc

3.74
-0.06 (-1.58%)
Apr 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
MaxCyte Inc MXCT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -1.58% 3.74 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.80 3.671 3.80 3.74 3.80
more quote information »

Recent News

Date Time Source Heading
4/10/202408:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
4/02/202408:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
3/12/202416:05GLOBEMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
3/05/202416:15EDGAR2Form 8-K - Current report
3/04/202417:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
3/04/202416:05GLOBEMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
2/26/202416:22EDGAR2Form 144 - Report of proposed sale of securities
2/14/202416:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202412:25EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/09/202408:05GLOBEMaxCyte to Report Fourth Quarter and Full Year 2023..
2/01/202416:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/30/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202408:05GLOBEMaxCyte and Wugen Sign Strategic Platform License to..
1/26/202416:45EDGAR2Form 8-K - Current report
1/26/202411:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/23/202408:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
1/08/202416:15EDGAR2Form 8-K - Current report
1/08/202416:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
1/04/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202408:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
1/02/202402:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
12/28/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202316:30EDGAR2Form 8-K - Current report
12/11/202316:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
12/06/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202316:32EDGAR2Form 144 - Report of proposed sale of securities
11/17/202316:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/16/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202308:05GLOBEMaxCyte Joins the Alliance for mRNA Medicines (AMM) as a..
11/08/202317:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:12EDGAR2Form 8-K - Current report
11/08/202316:05GLOBEMaxCyte Reports Third Quarter 2023 Financial Results and..
11/06/202316:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
10/04/202316:14EDGAR2Form 8-K - Current report
10/04/202316:05GLOBEMaxCyte Announces Preliminary Third Quarter 2023 Revenue and..
9/06/202308:05GLOBEMaxCyte Appoints Ali Soleymannezhad as Executive Vice..
9/05/202308:05GLOBEMaxCyte to Participate in Baird Global Healthcare Conference
8/30/202317:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202316:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:16EDGAR2Form 8-K - Current report
8/09/202316:05GLOBEMaxCyte Reports Second Quarter and Half-Year 2023 Financial..
8/01/202308:05GLOBEMaxCyte Signs Strategic Platform License with Prime Medicine..
7/28/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/13/202308:05GLOBEMaxCyte to Report Second Quarter 2023 Financial Results on..
7/12/202318:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/10/202316:51EDGAR2Form 144 - Report of proposed sale of securities
7/10/202308:05GLOBEMaxCyte and Vittoria Biotherapeutics Sign Strategic Platform..
7/06/202308:05GLOBEMaxCyte Signs Strategic Platform License with Lyell..

Your Recent History

Delayed Upgrade Clock